ADAM17 and lung cancer: In a previous study, LTA was found to be related to SCZ in genetic polymorphism variant (Arab and Elhawary 2015), and ADAM17 was identified as an emerging therapeutic target for lung cancer and its expression was revealed SCZ through the TNF pathway (Hoseth et al. 2017; Saad et al. 2019).